A highly efficient Cas9-mediated transcriptional programming system was developed, enabling precise and robust activation of endogenous genes. The study describes the rational design of a tripartite activator, VP64-p65-Rta (VPR), fused to nuclease-null Cas9 (dCas9). This fusion significantly enhances transcriptional activation compared to existing dCas9-VP64 systems. The VPR activator was tested in various cell types, including human cells, yeast, and flies, demonstrating improved activation across multiple genes. The system was further applied to induce neuronal differentiation of human induced pluripotent stem cells (iPSCs), showing a 10- to 37-fold increase in iNeuron production compared to dCas9-VP64. The study also highlights the importance of domain order in multi-component fusions and the potential of VPR as a powerful tool for gene regulation and cellular reprogramming. The results demonstrate that VPR can achieve activation levels comparable to native tissues, making it a valuable tool for therapeutic and research applications. The study also discusses the broader implications of the design process for future synthetic effectors, emphasizing the need for extensive screening and careful domain ordering. The work represents a significant advancement in the field of CRISPR-based gene regulation.A highly efficient Cas9-mediated transcriptional programming system was developed, enabling precise and robust activation of endogenous genes. The study describes the rational design of a tripartite activator, VP64-p65-Rta (VPR), fused to nuclease-null Cas9 (dCas9). This fusion significantly enhances transcriptional activation compared to existing dCas9-VP64 systems. The VPR activator was tested in various cell types, including human cells, yeast, and flies, demonstrating improved activation across multiple genes. The system was further applied to induce neuronal differentiation of human induced pluripotent stem cells (iPSCs), showing a 10- to 37-fold increase in iNeuron production compared to dCas9-VP64. The study also highlights the importance of domain order in multi-component fusions and the potential of VPR as a powerful tool for gene regulation and cellular reprogramming. The results demonstrate that VPR can achieve activation levels comparable to native tissues, making it a valuable tool for therapeutic and research applications. The study also discusses the broader implications of the design process for future synthetic effectors, emphasizing the need for extensive screening and careful domain ordering. The work represents a significant advancement in the field of CRISPR-based gene regulation.